Key result
Arrhythmogenic right ventricular cardiomyopathy is an increasingly recognized cause of sudden cardiac death in young athletes, though optimal treatment remains unclear.
Population
Young people, notably young athletes, with Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Design
Review
Authors
Loading...
Supports inclusion of ARVC in athlete SCD differentials; leaves optimal management unresolved pending prospective trials.
ARVC is an increasingly recognized cause of sudden cardiac death in young people, with unclear optimal treatment strategies.
McRae et al. (2001) studied this question. Arrhythmogenic right ventricular cardiomyopathy is an increasingly recognized cause of sudden cardiac death in young athletes, though optimal treatment remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: